Skip to main content
SpringerLink
Log in

Drug–Drug Combinations

  • Chapter
  • First Online:
Fundamentals of Antimicrobial Pharmacokinetics and Pharmacodynamics

Abstract

Antimicrobial combination therapy has a long history. The potential for synergy between two antimicrobial agents has been sought using in vitro techniques such as disk approximation, checkerboard titration, in vitro killing experiments with fixed drug concentrations, through the use of in vitro pharmacodynamic models, through animal models, and through retrospective and prospective clinical studies. The most widely examined combinations are those that include aminoglycosides, especially for the treatment of serious Pseudomonas aeruginosa infections, and for the management of enterococcal and staphylococcal endocarditis. The in vitro and animal studies of P. aeruginosa support the concept that combinations of aminoglycosides with β-lactams improve efficacy and outcomes. Some models suggest that the mechanism of improved efficacy relates less to synergy and more the prevention of the selection of aminoglycoside-resistant mutants. However, human clinical studies to date have failed to demonstrate convincingly that there are better outcomes with combination therapy in terms of efficacy or the prevention of resistance emergence. For endocarditis, there has been strong evidence accumulated for combination therapy enterococcal endocarditis using in vitro and animal models, although there are no randomised clinical data to confirm these. Data supporting the use of combination in staphylococcal therapy has been less robust, and the role of combination treatment for this indication is now in question. Ultimately, an in vitro or animal model of the pharmacodynamic interaction of drug classes that can be shown to predict clinical outcomes is still required. Such a model does not currently exist.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Aaron SD, Vandemheen KL, Ferris W, Fergusson D, Tullis E, Haase D, Berthiaume Y, Brown N, Wilcox P, Yozghatlian V, Bye P, Bell S, Chan F, Rose B, Jeanneret A, Stephenson A, Noseworthy M, Freitag A, Paterson N, Doucette S, Harbour C, Ruel M, MacDonald N (2005) Combination antibiotic susceptibility testing to treat exacerbations of cystic fibrosis associated with multiresistant bacteria: a randomised, double-blind, controlled clinical trial. Lancet 366:463–471

    CAS  PubMed  Google Scholar 

  • Abrams B, Sklaver A, Hoffman T, Greenman R (1979) Single or combination therapy of staphylococcal endocarditis in intravenous drug abusers. Ann Intern Med 90:789–791

    CAS  PubMed  Google Scholar 

  • Andes DR, Craig WA (1998) Pharmacodynamics of fluoroquinolones in experimental models of endocarditis. Clin Infect Dis 27:47–50

    CAS  PubMed  Google Scholar 

  • Aoki N, Tateda K, Kikuchi Y, Kimura S, Miyazaki C, Ishii Y, Tanabe Y, Gejyo F, Yamagichi K (2009) Efficacy of colistin combination therapy in a mouse model of pneumonia caused by multidrug-resistant Pseudomonas aeruginosa. J Antimicrob Chemother 63:534–542

    CAS  PubMed  Google Scholar 

  • Baddour LM, Wilson WR, Bayer AS, Fowler VG Jr, Bolger AF, Levison ME, Ferrieri P, Gerber MA, Tani LY, Gewitz MH, Tong DC, Steckelberg JM, Baltimore RS, Shulman ST, Burns JC, Falace DA, Newburger JW, Pallasch TJ, Takahashi M, Taubert KA, Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association, Infectious Diseases Society of America (2005) Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation 111:e394–e434

    PubMed  Google Scholar 

  • Barclay ML, Begg EJ, Chambers ST, Boswell DR (1995) Improved efficacy with nonsimultaneous administration of first doses of gentamicin and ceftazidime in vitro. Antimicrob Agents Chemother 39:132–136

    CAS  PubMed Central  PubMed  Google Scholar 

  • Basker MJ, Sutherland R (1977) Activity of amoxycillin, alone, and in combination with aminoglycosides antibiotics against streptococci associated with bacterial endocarditis. J Antimicrob Chemother 3:273–282

    CAS  PubMed  Google Scholar 

  • Batard E, Jacqueline C, Boutoille D, Hamel A, Drugeon HB, Asseray N, Leclercq R, Caillon J, Potel G, Bugnon D (2002) Combination of quinupristin-dalfopristin and gentamicin against methicillin-resistant Staphylococcus aureus: experimental rabbit endocarditis study. Antimicrob Agents Chemother 46:2174–2178

    CAS  PubMed Central  PubMed  Google Scholar 

  • Bayer AS, Lam K, Norman D, Kim KS, Morrison JO (1985a) Amikacin+ceftazidime therapy of experimental right-sided Pseudomonas aeruginosa endocarditis in rabbits. Chemotherapy 31:351–361

    CAS  PubMed  Google Scholar 

  • Bayer AS, Norman D, Kim KS (1985b) Efficacy of amikacin and ceftazidime in experimental aortic valve endocarditis due to Pseudomonas aeruginosa. Antimicrob Agents Chemother 28:781–785

    CAS  PubMed Central  PubMed  Google Scholar 

  • Bergen PJ (2008) Comparison of once-, twice- and thrice-daily dosing of colistin on the antibacterial effect and emergence of resistance: studies with Pseudomonas aeruginosa in an in vitro pharmacodynamic model. J Antimicrob Chemother 61:636–642

    CAS  PubMed  Google Scholar 

  • Bergen PJ, Tsuji BT, Bulitta J, Forrest A, Jacob J, Sidjabat HE, Paterson DL, Nation RL, Li J (2011) Synergistic killing of multidrug resistant Pseudomonas aeruginosa at multiple inocula by colistin combined with doripenem in an in vitro pharmacokinetic/pharmacodynamic model. Antimicrob Agents Chemother 55:5685–5695

    CAS  PubMed Central  PubMed  Google Scholar 

  • Blaser J, Stone BB, Groner MC, Zinner SH (1985) Impact of netilmicin regimens on the activities of ceftazidime-netilmicin combinations against Pseudomonas aeruginosa in an in vitro pharmacokinetic model. Antimicrob Agents Chemother 28:64–68

    CAS  PubMed Central  PubMed  Google Scholar 

  • Blaser J, Stone BB, Groner MC, Zinner SH (1987) Comparative study with enoxacin and netilmicin in a pharmacodynamic model to determine importance of ratio of antibiotic peak concentration to MIC for bactericidal activity and emergence of resistance. Antimicrob Agents Chemother 31:1054–1060

    CAS  PubMed Central  PubMed  Google Scholar 

  • Bliziotis IA, Samonis G, Vardakas KZ, Chrysaanthopoulou S, Falagas ME (2005) Effect of aminoglycoside and lactam combination therapy versus β-lactam monotherapy on the emergence of antimicrobial resistance: a meta-analysis of randomized, controlled trials. Clin Infect Dis 41:149–158

    CAS  PubMed  Google Scholar 

  • Boffi El Amari E, Chamot E, Auckenthaler R, Pechère JC, van Delden C (2001) Influence of previous exposure to antibiotic therapy on the susceptibility pattern of Pseudomonas aeruginosa bacteremic isolates. Clin Infect Dis 33:1859–1864

    Google Scholar 

  • Bonapace CR, Bosso JA, Friedrich LV, White RL (2002) Comparison of methods of interpretation of checkerboard synergy testing. Diag Microbiol Infect Dis 44:363–366

    Google Scholar 

  • Boucher AN, Tam VH (2006) Mathematical formulation of additivity for antimicrobial agents. Diag Microbiol Infect Dis 55:319–325

    CAS  Google Scholar 

  • Bouvet A, Cremieux AC, Contrepois A, Vallois JM, Lamesch C, Carbon C (1985) Comparison of penicillin and vancomycin, individually and in combination with gentamicin and amikacin, in the treatment of experimental endocarditis induced by nutritionally variant streptococci. Antimicrob Agents Chemother 28:607–611

    CAS  PubMed Central  PubMed  Google Scholar 

  • Brandt CM, Warner CB, Rouse MS, Steckelberg JM, Wilson WR (1996) Effect of gentamicin dosing interval on efficacy of penicillin or ceftriaxone treatment of experimental endocarditis due to penicillin-susceptible, ceftriaxone-tolerant viridans group streptococci. Antimicrob Agents Chemother 40:2901–2903

    CAS  PubMed Central  PubMed  Google Scholar 

  • Bugnon D, Potel G, Xiong YQ, Caillon J, Navas D, Gras C, Kergueris MF, Le Conte P, Jehl F, Baron D, Drugeon H (1997) Bactericidal effect of pefloxacin and fosfomycin against Pseudomonas aeruginosa in a rabbit endocarditis model with pharmacokinetics of pefloxacin in humans simulated in vivo. Eur J Clin Microbiol Infect Dis 16:575–580

    CAS  PubMed  Google Scholar 

  • Carmeli Y, Troillet N, Eliopoulos GM, Samore MH (1999) Emergence of antibiotic-resistant Pseudomonas aeruginosa: comparison of risks associated with different antipseudomonal agents. Antimcrob Agents Chemother 43:1379–1382

    CAS  Google Scholar 

  • Caron F, Carbon C, Gutmann L (1991) Triple-combination penicillin-vancomycin-gentamicin for experimental endocarditis caused by a moderately penicillin- and highly glycopeptide-resistant isolate of Enterococcus faecium. J Infect Dis 164:888–893

    CAS  PubMed  Google Scholar 

  • Caron F, Kitzis MD, Gutmann L, Cremieux AC, Maziere B, Vallois JM, Saleh-Mghir A, Lemeland JF, Carbon C (1992) Daptomycin or teicoplanin in combination with gentamicin for treatment of experimental endocarditis due to a highly glycopeptide-resistant isolate of Enterococcus faecium. Antimicrob Agents Chemother 36:2611–2616

    CAS  PubMed Central  PubMed  Google Scholar 

  • Caron F, Lemeland JF, Humbert G, Klare I, Gutmann L (1993) Triple combination penicillin-vancomycin-gentamicin for experimental endocarditis caused by a highly penicillin-and glycopeptide-resistant isolate of Enterococcus faecium. J Infect Dis 168:681–686

    CAS  PubMed  Google Scholar 

  • Cates JE, Christie RV, Garrod LP (1951) Penicillin-resistant subacute bacterial endocarditis treated by a combination of penicillin and streptomycin. Br Med J 1(4708):653–656

    CAS  PubMed Central  PubMed  Google Scholar 

  • Chadwick EG, Shulman ST, Yogev R (1986) Correlation of antibiotic synergy in vitro and in vivo: use of an animal model of neutropenic gram-negative sepsis. J Infect Dis 154:670–675

    CAS  PubMed  Google Scholar 

  • Chambers HF, Miller MH (1987) Emergence of resistance to cephalothin and gentamicin during combination therapy for methicillin-resistant Staphylococcus aureus endocarditis in rabbits. J Infect Dis 155:581–585

    CAS  PubMed  Google Scholar 

  • Chambers HF, Kartalija M, Sande M (1995) Ampicillin, sulbactam, and rifampin combination treatment of experimental methicillin-resistant Staphylococcus aureus endocarditis in rabbits. J Infect Dis 171:897–902

    CAS  PubMed  Google Scholar 

  • Chamot E, Boffi El Amari E, Rohner P, van Delden C (2003) Effectiveness of combination therapy for Pseudomonas aeruginosa bacteremia. Antimicrob Agents Chemother 47:2756–2764

    CAS  PubMed Central  PubMed  Google Scholar 

  • Chan E, Zhou S, Srikumar S, Duan W (2006) Use of in vitro critical inhibitory concentration, a novel approach to predict in vivo synergistic bactericidal effect of combined amikacin and piperacillin against Pseudomonas aeruginosa in a systemic rat infection model. Pharm Res 223:729–741

    Google Scholar 

  • Chandrasekar PH, Crane LR, Bailey EJ (1987) Comparison of the activity of antibiotic combinations in vitro with clinical outcome and resistance emergence in serious infection by Pseudomonas aeruginosa in non-neutropenic patients. J Antimicrob Chemother 19:321–329

    CAS  PubMed  Google Scholar 

  • Chatzinikolaou I, Abi-Daid D, Bodey GP, Rolston KV, Tarrand JJ, Samonis G (2000) Recent experience with Pseudomonas aeruginosa bacteremia in patients with cancer. Retrospective analysis of 245 episodes. Arch Int Med 160:501–509

    CAS  Google Scholar 

  • Chen HY, Williams JD (1983) The killing effects of cefathiamidine or ampicillin alone and in combination with gentamicin against enterococci. J Antimicrob Chemother 12:19–26

    CAS  PubMed  Google Scholar 

  • Chiang FY, Climo M (2003) Efficacy of linezolid alone or in combination with vancomycin for treatment of experimental endocarditis due to methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 47:3002–3004

    CAS  PubMed Central  PubMed  Google Scholar 

  • Chin NX, Jules K, Neu HC (1986) Synergy of ciprofloxacin and azlocillin in vitro and in a neutropenic mouse model of infection. Eur J Clin Microbiol 5:23–28

    CAS  PubMed  Google Scholar 

  • Chusid MJ, Davis SD, Sarff LD (1983) Experimental Pseudomonas aeruginosa sepsis: absence of synergy between ticarcillin and tobramycin. J Lab Clin Med 101:441–449

    CAS  PubMed  Google Scholar 

  • Cirioni O, Ghiselli R, Orlando F, Silvestri C, Mocchegiani F, Rocchi M, Chiodi L, Abbruzzetti A, Saba V, Giacometti A (2007) Efficacy of colistin/rifampin combination in experimental models of sepsis due to multi-resistant Pseudomonas aeruginosa. Crit Care Med 35:1717–1723

    CAS  PubMed  Google Scholar 

  • Cosgrove SE, Vigliani GA, Fowler VG Jr, Abrutyn E, Corey GR, Levine DP, Rupp ME, Chambers HF, Karchmer AW, Boucher HW (2009) Initial low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxic. Clin Infect Dis 48:713–721

    PubMed  Google Scholar 

  • Costa Y, Galimand M, Leclercq R, Duval J, Courvalin P (1993) Characterization of the chromosomal aac(6’)-Ii gene specific for Enterococcus faecium. Antimicrob Agents Chemother 23:36–41

    Google Scholar 

  • Cremieux AC, Carbon C (1992) Pharmacokinetic and pharmacodynamic requirements for antibiotic therapy of experimental endocarditis. Antimicrob Agents Chemother 36:2069–2074

    CAS  PubMed Central  PubMed  Google Scholar 

  • Cremieux AC, Maziere B, Vallois JM, Ottaviani M, Azancot A, Raffoul H, Bouvet A, Pocidalo JJ, Carbon C (1989) Evaluation of antibiotic diffusion into cardiac vegetations by quantitative autoradiography. J Infect Dis 159:938–944

    CAS  PubMed  Google Scholar 

  • Cremieux AC, Saleh-Mghir A, Vallois JM, Maziere B, Muffat-Joly M, Devine C, Bouvet A, Pocidalo JJ, Carbon C (1992) Efficacy of temafloxacin in experimental Streptococcus adjacens endocarditis and autoradiographic diffusion pattern of [14C]temafloxacin in cardiac vegetations. Antimicrob Agents Chemother 36:2216–2221

    CAS  PubMed Central  PubMed  Google Scholar 

  • Croisier D, Martha B, Piroth L, Chavanet P (2008) In vivo efficacy of humanised intermittent versus continuous ceftazidime with tobramycin in an experimental model of pseudomonal pneumonia. Int J Antimicrob Agents 32:494–498

    CAS  PubMed  Google Scholar 

  • den Hollander JG, Horrevorts AM, van Goor M-JPJ, Verbrugh HA, Mouton JW (1997) Synergism between tobramycin and ceftazidime against a resistant Pseudomonas aeruginosa strain. tested in an in vitro pharmacokinetic model. Antimicrob Agents Chemother 41:95–100

    Google Scholar 

  • den Hollander JG, Mouton JW, Verbrugh HA (1998) Use of pharmacodynamic parameters to predict efficacy of combination therapy by using fractional inhibitory concentration kinetics. Antimicrob Agents Chemother 42:744–748

    Google Scholar 

  • DeRyke CA, Lee SY, Kuti JL, Nicolau DP (2006) Optimising dosing strategies of antibacterials utilising pharmacodynamic principles: impact on the development of resistance. Drugs 66:1–14

    CAS  PubMed  Google Scholar 

  • Drinković D, Morris AJ, Pottumarthy S, MacCulloch D, West T (2003) Bacteriological outcome of combination versus single-agent treatment for staphylococcal endocarditis. J Antimicrob Chemother 52:820–825

    PubMed  Google Scholar 

  • Drusano GL, Bonomo RA, Bahniuk N, Bulitta JB, van Scoy B, DeFiglio H, Fikes S, Brown D, Drwaz SM, Kulawy R, Louie A (2012) Resistance emergence mechanism and mechanism resistance suppression by tobramycin for cefepime for Pseudomonas aeruginosa. Antimicrob Agents Chemother 56(1):231–242

    CAS  PubMed Central  PubMed  Google Scholar 

  • Dudley MN, Mandler HD, Gilbert D, Ericson J, Mayer KH, Zinner SH (1987) Pharmacokinetics and pharmacodynamics of intravenous ciprofloxacin. Studies in vivo and in an in vitro dynamic model. Am J Med 82:363–368

    CAS  PubMed  Google Scholar 

  • Dudley MN, Blaser J, Gilbert D, Mayer KH, Zinner SH (1991) Combination therapy with ciprofloxacin plus azlocillin against Pseudomonas aeruginosa: effect of simultaneous versus staggered administration. J Infect Dis 164:499–506

    CAS  PubMed  Google Scholar 

  • Dundar D, Otkun M (2010) In-vitro efficacy of synergistic antibiotic combinations in multidrug resistant Pseudomonas aeruginosa strains. Yonsei Med J 51:111–116

    CAS  PubMed Central  PubMed  Google Scholar 

  • Duperval R, Bill NJ, Geraci JE, Washington JA 2nd (1975) Bactericidal activity of combinations of penicillin or clindamycin with gentamicin or streptomycin against species of viridans streptococci. Antimicrob Agents Chemother 8:673–676

    CAS  PubMed Central  PubMed  Google Scholar 

  • Elion GB, Singer S, Hitchings CH (1954) Antagonists of nucleic acid derivatives. VIII. Synergism in combinations of biochemically related metabolites. J Biol Chem 208:477–488

    CAS  PubMed  Google Scholar 

  • Eliopoulos GM, Eliopoulous CT (1988) Antibiotic combinations: should they be tested? Clin Microbiol Rev 1:139–156

    CAS  PubMed Central  PubMed  Google Scholar 

  • Eliopoulos GM, Moellering RC Jr (1996) Antimicrobial combinations. In: Lorian V (ed) Antibiotics in laboratory medicine, 4th edn. Williams & Wilkins, Baltimore

    Google Scholar 

  • Fantin B, Carbon C (1990) Importance of the aminoglycoside dosing regimen in the penicillin-netilmicin combination for treatment of Enterococcus faecalis-induced experimental endocarditis. Antimicrob Agents Chemother 34:2387–2391

    CAS  PubMed Central  PubMed  Google Scholar 

  • Fantin B, Carbon C (1992) In vivo antibiotic synergism: contribution of animal models. Antimicrob Agents Chemother 36:907–912

    CAS  PubMed Central  PubMed  Google Scholar 

  • Fantin B, Leclercq R, Duval J, Carbon C (1993) Fusidic acid alone or in combination with vancomycin for therapy of experimental endocarditis due to methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 37:2466–2469

    CAS  PubMed Central  PubMed  Google Scholar 

  • Fantin B, Leclercq R, Ottaviani M, Vallois JM, Maziere B, Duval J, Pocidalo JJ, Carbon C (1994) In vivo activities and penetration of the two components of the streptogramin RP 59500 in cardiac vegetations of experimental endocarditis. Antimicrob Agents Chemother 38:432–437

    CAS  PubMed Central  PubMed  Google Scholar 

  • Farber BF, Yee Y (1987) High-level aminoglycoside resistance mediated by aminoglycoside-modifying enzymes among viridans streptococci: implications for the therapy for endocarditis. J Infect Dis 155:948–953

    CAS  PubMed  Google Scholar 

  • Farber BF, Eliopoulos GM, Ward JI, Ruoff K, Moellering RC Jr (1983) Resistance to penicillin-streptomycin synergy among clinical isolates of viridans streptococci. Antimicrob Agents Chemother 24:871–875

    CAS  PubMed Central  PubMed  Google Scholar 

  • Fass RJ, Wright CA (1984) Comparative efficacies of mezlocillin and ampicillin alone or in combination with gentamicin in the treatment of Streptococcus faecalis endocarditis in rabbits. Antimicrob Agents Chemother 25:408–410

    CAS  PubMed Central  PubMed  Google Scholar 

  • Foweraker JE, Laughton CR, Brown DF, Bilton D (2009) Comparison of methods to test antibiotic combinations against heterogeneous populations of multiresistant Pseudomonas aeruginosa from patients with acute infective exacerbations in cystic fibrosis. Antimicrob Agents Chemother 53:4809–4815

    CAS  PubMed Central  PubMed  Google Scholar 

  • Fox PM, Lampen RJ, Stumpf KS, Archer GL, Climo MW (2006) Successful therapy of experimental endocarditis caused by vancomycin-resistant Staphylococcus aureus with a combination of vancomycin and beta-lactam antibiotics. Antimicrob Agents Chemother 50:2951–2956

    CAS  PubMed Central  PubMed  Google Scholar 

  • Froidefond S, Saivin S, Lemozy J, Marchou B, Auvergnat JC, Dabernet H (1992) Resistance to antibiotic treatment produced in a model of experimental Pseudomonas aeruginosa peritonitis. Pathol Biol (Paris) 40:573–582

    CAS  Google Scholar 

  • Fujimura S, Takane H, Nakano Y, Watanabe A (2009) In vitro synergy studies based on tazobactam/piperacillin against clinical isolates of metallo-β-lactamase-producing Pseudomonas aeruginosa. J Antimicrob Chemother 64:1115–1116

    CAS  PubMed  Google Scholar 

  • Garnacho-Montero J, Sa-Borges M, Sole-Violan J (2007) Optimal management therapy for Pseudomonas aeruginosa ventilator-associated pneumonia: an observational, multicentre study comparing monotherapy with combination antibiotic therapy. Crit Care Med 35:1888–1895

    CAS  PubMed  Google Scholar 

  • Gavaldà J, Pahissa A, Almirante B, Laguarda M, Crspo E, Pou L, Fernández F (1995) Effect of gentamicin dosing interval on therapy of viridans streptococcal experimental endocarditis with gentamicin and penicillin. Antimicrob Agents Chemother 39:2098–2103

    PubMed Central  PubMed  Google Scholar 

  • Gavaldà J, Cardona PJ, Almirante B, Capdevila JA, Laguarda M, Pou L, Crespo E, Pigrau C, Pahissa A (1997) Treatment of experimental endocarditis due to Enterococcus faecalis using once-daily dosing regimen of gentamicin plus simulated profiles of ampicillin in human serum. Antimicrob Agents Chemother 40:173–178

    Google Scholar 

  • Gengo FM, Mannion TW, Nightingale CH, Shentag JJ (1984) Integration of pharmacokinetics and pharmacodynamics of methicillin in curative treatment of experimental endocarditis. J Antimicrob Chemother 14:619–631

    CAS  PubMed  Google Scholar 

  • Geraci JE, Martin WJ (1954) Antibiotic therapy of bacterial endocarditis. VI. Subacute enterococcal endocarditis; clinical, pathologic and therapeutic consideration of 33 cases. Circulation 10:173–194

    CAS  PubMed  Google Scholar 

  • Gerber AU, Craig WA (1982) Aminoglycoside-selected subpopulations of Pseudomonas aeruginosa: characterization and virulence in normal and leukopenic mice. J Lab Clin Med 100:671–681

    CAS  PubMed  Google Scholar 

  • Gerber AU, Vastola AP, Brandel J, Craig WA (1982) Selection of aminoglycoside-resistant variants of Pseudomonas aeruginosa in an in vivo model. J Infect Dis 146:691–697

    CAS  PubMed  Google Scholar 

  • Gerber AU, Craig WA, Brugger H-P, Feller C, Vastola AP, Brandel J (1983) Impact of dosing intervals on the efficacy of gentamicin and ticarcillin against Pseudomonas aeruginosa in granulocytopenic mice. J Infect Dis 147:910–917

    CAS  PubMed  Google Scholar 

  • Gerber AU, Kozak S, Segessenmann C, Flückiger U, Bangerer T, Greter U (1989) Once-daily versus thrice-daily administration of netilmicin in combination therapy of Pseudomonas aeruginosa infection in a man-adapted neutropenic animal model. Eur J Clin Microbiol Infect Dis 8:233–237

    CAS  PubMed  Google Scholar 

  • Gilbert DN, Moellering RC, Eliopoulos GM, Chambers HF, Saag MS (2011) The Sanford guide to antimicrobial therapy, 41st edn. Antimicrobial Therapy, Sperryville

    Google Scholar 

  • Giwercman B, Høiby N (1991) Pseudomonas aeruginosa resistance to beta-lactam antibiotics. Infect Dis Newsl 10:97–101

    Google Scholar 

  • Glew RH, Moellering RC Jr (1979) Effect of protein binding on the activity of penicillins in combination with gentamicin against enterococci. Antimicrob Agents Chemother 15:87–92

    CAS  PubMed Central  PubMed  Google Scholar 

  • Gordin FM, Rusnak MG, Sande MA (1987) Evaluation of combination chemotherapy in a lightly anesthetized animal model of Pseudomonas pneumonia. Antimicrob Agents Chemother 31:398–403

    CAS  PubMed Central  PubMed  Google Scholar 

  • Greco WR, Bravo G, Parsons JC (1995) The search for synergy: a critical review from a response surface perspective. Pharmacol Rev 47:331–385

    CAS  PubMed  Google Scholar 

  • Gribble MJ, Chow AW, Naiman SC, Smith JA, Bowie WR, Sacks SL, Grossman L, Buskard N, Growe GH, Plenderleith LH (1983) Prospective randomized trial of piperacillin monotherapy versus carboxypenicillin-aminoglycoside regimens in empirical treatment of serious bacterial infections. Antimicrob Agents Chemother 24:388–393

    CAS  PubMed Central  PubMed  Google Scholar 

  • Gudmundsson S, Einarsson S, Erlensdottir H, Moffat J, Bayer W, Craig WA (1993) The post-antibiotic effect of antimicrobial combinations in a neutropenic murine thigh infection model. J Antimicrob Chemother 31(Suppl D):177–191

    CAS  PubMed  Google Scholar 

  • Guggenbichler JP, Allernerger F, Dierich MP, Schmitzberger R, Semenitz E (1988) Spaced administration of antibiotic combinations to eliminate Pseudomonas from sputum in cystic fibrosis patients. Lancet 2:749–750

    CAS  PubMed  Google Scholar 

  • Gunderson BW, Inbrahim KH, Hovde LB, Fromm TL, Reed MD, Rotschafer JC (2003) Synergistic activity of colistin and ceftazidime against multiantibiotic-resistant Pseudomonas aeruginosa in an in vitro pharmacodynamic model. Antimicrob Agents Chemother 47:905–909

    PubMed Central  PubMed  Google Scholar 

  • Hansen GT, Zhao X, Crlica K, Blondeau JM (2006) Mutant prevention concentration for ciprofloxacin and levofloxacin with Pseudomonas aeruginosa. Int J Antimicrob Agents 27:120–124

    CAS  PubMed  Google Scholar 

  • Hershberger E, Coyle EA, Kaatz GW, Zervos MJ, Rybak MJ (2000) Comparison of a rabbit model of bacterial endocarditis and an in vitro infection model with simulated endocardial vegetations. Antimicrob Agents Chemother 44:1921–1924

    CAS  PubMed Central  PubMed  Google Scholar 

  • Hilf M, Yu VL, Sharp J, Zuraleff JJ, Korvick JA, Muder RR (1989) Antibiotic therapy for Pseudomonas aeruginosa bacteremia: outcome correlations in a prospective study of 200 patients. Am J Med 87:540–546

    CAS  PubMed  Google Scholar 

  • Houlihan HH, Stokes DP, Rybak MJ (2000) Pharmacodynamics of vancomycin and ampicillin alone and in combination with gentamicin once daily or thrice daily against Enterococcus faecalis in an in vitro infection model. J Antimicrob Chemother 46:79–86

    CAS  PubMed  Google Scholar 

  • Hunter TH (1946) The treatment of subacute bacterial endocarditis with antibiotics. Am J Med 1:83–92

    CAS  PubMed  Google Scholar 

  • Hunter TH (1947) Use of streptomycin in the treatment of bacterial endocarditis. Am J Med 2:436–442

    CAS  PubMed  Google Scholar 

  • Ingerman MJ, Pitsakis PG, Rosenberg AF, Levison ME (1986) The importance of pharmacodynamics in determining the dosing interval in therapy for experimental Pseudomonas endocarditis in the rat. J Infect Dis 153:707–714

    CAS  PubMed  Google Scholar 

  • Jacqueline C, Asseray N, Batard E, Le Mabecque V, Kergueris MF, Dube L, Bugnon D, Potel G, Caillon J (2004) In vivo efficacy of linezolid in combination with gentamicin for the treatment of experimental endocarditis due to methicillin-resistant Staphylococcus aureus. J Antimicrob Agents 24:393–396

    CAS  Google Scholar 

  • Jawetz E, Gunnison JB (1950) The determination of sensitivity to penicillin and streptomycin of enterococci and streptococci of the viridans group. J Lab Clin Med 35:488–496

    Google Scholar 

  • Jawetz E, Sonne M (1965) Penicillin-streptomycin treatment of enterococcal endocarditis. New Engl J Med 274:710–715

    Google Scholar 

  • Jawetz E, Gunnison JB, Coleman VR (1950) The combined action of penicillin and streptomycin or chloromycetin on enterococci in vitro. Science 111:254–256

    CAS  PubMed  Google Scholar 

  • Johnson D (1985) Use of discriminatory models of Pseudomonas aeruginosa bacteremia in granulocytpenic rats for testing antimicrobial efficacy. Eur J Clin Microbiol 4:207–212

    CAS  PubMed  Google Scholar 

  • Johnson DE, Thompson B (1986) Efficacy of single-agent therapy with azlocillin, ticarcillin, and amikacin and β-lactam/amikacin combinations for the treatment of Pseudomonas aeruginosa bacteremia in granulocytopenic rats. Am J Med 80(5C):53–58

    CAS  PubMed  Google Scholar 

  • Johnson M, Miniter P, Andriole VT (1987) Comparative efficacy of ciprofloxacin, azlocillin, and tobramycin alone and in combination in experimental Pseudomonas sepsis. J Infect Dis 155:783–788

    CAS  PubMed  Google Scholar 

  • Join-Lambert O, Mainardi JL, Cuvelier C, Dautrey S, Farinotti R, Fantin B, Carbon C (1998) Critical importance of in vivo amoxicillin and cefotaxime concentrations for synergy in treatment of experimental Enterococcus faecalis endocarditis. Antimicrob Agents Chemother 42:468–470

    CAS  PubMed Central  PubMed  Google Scholar 

  • Kaatz GW, Seo SM, Barriere SL, Albrecht LM, Rybak MJ (1989) Ciprofloxacin and rifampin, alone and in combination, for therapy of experimental Staphylococcus aureus endocarditis. Antimicrob Agents Chemother 33:1184–1187

    CAS  PubMed Central  PubMed  Google Scholar 

  • Kanellakopoulou K, Sarafis P, Galani I, Giamarellou H, Giamarellos-Bourboulis EJ (2008) In vitro synergism of beta-lactams with ciprofloxacin and moxifloxacin against genetically distinct multidrug-resistant isolates of Pseudomonas aeruginosa. Int J Antimicrob Agents 32:33–39

    CAS  PubMed  Google Scholar 

  • Kang CI, Kim SH, Kim HB, Park SW, Choe YJ, Oh MD, Kim EC, Choe KW (2003) Pseudomonas aeruginosa bacteremia: risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on outcomes. Clin Infect Dis 37:745–751

    PubMed  Google Scholar 

  • Kemmerich B, Small GJ, Pennington JE (1986) Comparative evaluation of ciprofloxacin, enoxacin, and ofloxacin in experimental Pseudomonas aeruginosa pneumonia. Antimicrob Agents Chemother 29:395–399

    CAS  PubMed Central  PubMed  Google Scholar 

  • Klastersky J, Cappel R, Daneau D (1973) Therapy with carbenicillin and gentamicin for patients with cancer and severe infections caused by gram-negative rods. Cancer 31:331–336

    CAS  PubMed  Google Scholar 

  • Korzeniowski O, Sande MA (1982) Combination antimicrobial therapy for Staphylococcus aureus endocarditis in patients addicted to parenteral drugs and in nonaddicts: a prospective study. Ann Intern Med 97:496–503

    CAS  PubMed  Google Scholar 

  • Kosmidis J, Koatzanis G (1986) Emergence of resistant bacterial strains during treatment of infections of the respiratory tract. Scand J Infect Dis Suppl 49:135–138

    CAS  PubMed  Google Scholar 

  • Kuikka A, Valtonen VV (1998) Factors associated with improved outcome of Pseudomonas aeruginosa bacteremia in a Finnish university hospital. Eur J Clin Microbiol Infect Dis 17:701–708

    CAS  PubMed  Google Scholar 

  • LaPlante KL, Rybak MJ (2004) Impact of high-inoculum Staphylococcus aureus on the activities of nafcillin, vancomycin, linezolid, and daptomycin, alone and in combination with gentamicin, in an in vitro pharmacodynamic model. Antimicrob Agents Chemother 48:4665–4672

    CAS  PubMed Central  PubMed  Google Scholar 

  • LaPlante KL, Woodmansee S (2009) Activities of daptomycin and vancomycin alone and in combination with rifampin and gentamicin against biofilm-forming methicillin-resistant Staphylococcus aureus isolates in an experimental model of endocarditis. Antimicrob Agents Chemother 53:3880–3886

    CAS  PubMed Central  PubMed  Google Scholar 

  • Le T, Bayer AS (2003) Combination antibiotic therapy for infective endocarditis. Clin Infect Dis 36:615–621

    PubMed  Google Scholar 

  • Lee DG, Chun HS, Yim DS, Choi SM, Choi JH, Yoo JH, Shin WS, Kang MW (2003) Efficacies of vancomycin, arbekacin, and gentamicin alone or in combination against methicillin-resistant Staphylococcus aureus in an in vitro infective endocarditis model. Antimicrob Agents Chemother 47:3768–3773

    CAS  PubMed Central  PubMed  Google Scholar 

  • Lefort A, Baptista M, Fantin B, Depardieu F, Arthur M, Carbon C, Courvalin P (1999) Two-step acquisition of resistance to the teicoplanin-gentamicin combination by VanB-type Enterococcus faecalis in vitro and in experimental endocarditis. Antimicrob Agents Chemother 43:476–482

    CAS  PubMed Central  PubMed  Google Scholar 

  • Lemonovich TL, Haynes K, Lautenbach E, Amorosa VK (2011) Combination therapy with an aminoglycoside for Staphylococcus aureus endocarditis and/or persistent bacteremia is associated with a decreased rate of recurrent bacteremia: a cohort study. Infection 39:549–554

    CAS  PubMed Central  PubMed  Google Scholar 

  • Lim T-P, Ledesma KR, Chang K-T, Hou J-G, Kwa AL, Nikolaou M, Quinn JP, Prince RA, Tam VH (2008) Quantitative assessment of combination antimicrobial therapy against multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother 52:2898–2904

    CAS  PubMed Central  PubMed  Google Scholar 

  • Lister PD, Sanders WE, Sanders CC (1998) Cefepime-aztreonam: a unique double β-lactam combination for Pseudomonas aeruginosa. Antimicrob Agents Chemother 42:1610–1619

    CAS  PubMed Central  PubMed  Google Scholar 

  • Lister PD, Wolter DJ, Wickman PA, Reisbig MD (2006) Levofloxacin/imipenem prevents the mergence of high-level resistance among Pseudomonas aeruginosa strains already lacking susceptibility to bother drugs. J Antimicrob Chemother 57:999–1003

    CAS  PubMed  Google Scholar 

  • Livermore DM (2002) Mutliple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare? Clin Infect Dis 34:634–640

    CAS  PubMed  Google Scholar 

  • Louie A, Grasso C, Bahniuk N, van Scoy B, Browen DL, Kulawy R, Drusano GL (2010) The combination of meropenem and levofloxacin is synergistic with respect to both Pseudomonas aeruginosa kill rate and resistance suppression. Antimicrob Agents Chemother 54:2646–2654

    CAS  PubMed Central  PubMed  Google Scholar 

  • MacGowan AP, Rogers CA, Holt HA, Bowker KE (2003) Activities of moxifloxacin against, and emergence of resistance in, Streptococcus pneumoniae and Pseudomonas aeruginosa in an in vitro pharmacodynamic model. Antimicrob Agents Chemother 47:1088–1095

    CAS  PubMed Central  PubMed  Google Scholar 

  • Maciá MD, Borrell N, Segura M, Gómez C, Pérez JL, Oliver A (2006) Efficacy and potential for resistance selection of antipseudomonal treatments in a mouse model of lung infection by hypermutable Pseudomonas aeruginosa. Antimicrob Agents Chemother 50:975–983

    PubMed Central  PubMed  Google Scholar 

  • Maiques JM, Doménich A, Cabellos C, Fernández R, Tubau F, Guidol F, Viladrich P (2007) Evalualtion of antibacterial regimens in a guinea-pig model of meningitis caused by Pseudomonas aeruginosa. Microbes Infect 9:435–441

    CAS  PubMed  Google Scholar 

  • Malacoff RF, Frank E, Andriole VT (1979) Streptococcal endocarditis (nonenterococcal, non-group A): single vs combination therapy. JAMA 241:1807–1810

    CAS  PubMed  Google Scholar 

  • Marangos MN, Nicolau DP, Quintiliani R, Nightingale CH (1997) Influence of gentamicin dosing interval on the efficacy of penicillin-containing regimens in experimental Enterococcus faecalis endocarditis. J Antimicrob Chemother 39:519–522

    CAS  PubMed  Google Scholar 

  • McGrath BJ, Lamp KC, Rybak MJ (1993) Pharmacodynamic effects of extended dosing interval of Imipenem alone and in combination with amikacin against Pseudomonas aeruginosa in an in vitro model. Antimicrob Agents Chemother 37:1931–1937

    CAS  PubMed Central  PubMed  Google Scholar 

  • McGrath BJ, Kang SL, Kaatz GW, Rybak MJ (1994) Bactericidal activities of teicoplanin, vancomycin, and gentamicin alone and in combination against Staphylococcus aureus in an in vitro pharmacodynamic model of endocarditis. Antimicrob Agents Chemother 38:2034–2040

    CAS  PubMed Central  PubMed  Google Scholar 

  • McLaughlin FJ, Matthews WJ Jr, Strieder DJ, Sullivan B, Taneja A, Murphy P, Goldmann DA (1983) Clinical and bacteriological responses to three antibiotic regimens for acute exacerbations of cystic fibrosis: ticarcillin-tobramycin, azlocillin-tobramycin, and azlocillin-placebo. J Infect Dis 147:559–567

    CAS  PubMed  Google Scholar 

  • Megran DW (1992) Enterococcal endocarditis. Clin Infect Dis 15:63–71

    CAS  PubMed  Google Scholar 

  • Mendelson MH, Gurtman A, Szabo S, Neinart E, Meyers BR, Policar M, Cheung TW, Lillienfeld D, Hammer G, Reddy S, Choi K, Hirschman SZ (1994) Pseudomonas aeruginosa bacteremia in patients with AIDS. Clin Infect Dis 18:886–895

    CAS  PubMed  Google Scholar 

  • Michalsen H, Bergan T (1981) Azlocillin with and without an aminoglycoside against respiratory tract infections in children with cystic fibrosis. Scand J Infect Dis Suppl 29:92–97

    CAS  PubMed  Google Scholar 

  • Miller MH, Wexler MA, Steigbigel NH (1978) Single and combination antibiotic therapy of Staphylococcus aureus experimental endocarditis: emergence of gentamicin-resistant mutants. Antimicrob Agents Chemother 14:336–343

    CAS  PubMed Central  PubMed  Google Scholar 

  • Miller MH, El Sokkary SA, Chow RT (1986) Penicillin-induced effects of streptomycin uptake and early bactericidal activity differ in viridans group and enterococcal streptococci. Antimcrob Agents Chemother 30:763–768

    CAS  Google Scholar 

  • Milne KEN, Gould IM (2010) Combination testing of multidrug-resistant cystic fibrosis isolates of Pseudomonas aeruginosa: use of a new parameter, the susceptible breakpoint index. J Antimicrob Chemother 65:82–90

    CAS  PubMed  Google Scholar 

  • Mimoz O, Elhelali N, Léotard S, Jacolet A, Laurent F, Samii K, Petitjean O, Nordmann P (1999) Treatment of experimental pneumonia in rats caused by a PER-1 extended-spectrum β-lactamase-producing strain of Pseudomonas aeruginosa. J Antimicrob Chemother 44:91–97

    CAS  PubMed  Google Scholar 

  • Moellering TC Jr, Weinberg AN (1971) Studies on antibiotic synergism against enterococci. II. Effect of various antibiotics on the uptake pf 14C-labelled streptomycin by enterococci. J Clin Invest 50:2580–2584

    CAS  PubMed Central  PubMed  Google Scholar 

  • Moellering RC Jr, Wennersten CB, Medrek T, Weinberg AN (1970) Prevalence of high-level resistance to aminoglycosides in clinical isolates of enterococci. Antimicrob Agents Chemother 10:335–360

    PubMed  Google Scholar 

  • Moellering RC, Wennersten C, Weinberg AN (1971) Synergy of penicillin and gentamicin against enterococci. J Infect Dis 124(Suppl):S207–S209

    CAS  PubMed  Google Scholar 

  • Moody JA, Fasching CE, Peterson LR, Gerding DN (1987) Ceftazidime and amikacin alone and in combination against Pseudomonas aeruginosa and Enterobacteriaceae. Diagn Microbiol Infect Dis 6:59–67

    CAS  PubMed  Google Scholar 

  • Mordenti JJ, Quintiliani R, Nightingale CH (1985) Combination antibiotic therapy: comparison of constant infusion and intermittent bolus dosing in an experimental model. J Antimicrob Chemother 25:313–321

    Google Scholar 

  • Mouton JW (1999) Combination therapy as a tool to prevent emergence of bacterial resistance. Infection 27(Suppl 2):S24–S28

    PubMed  Google Scholar 

  • Mouton JW, van Ogtrop ML, Andes D, Craig WA (1999) Use of pharmacodynamic indicies to predict efficacy of combination therapy in vivo. Antimicrob Agents Chemother 43:2473–2478

    CAS  PubMed Central  PubMed  Google Scholar 

  • Murray HW, Wigley FM, Mann JJ, Arthur RR (1976) Combination antibiotic therapy in staphylococcal endocarditis. The use of methicillin sodium-gentamicin sulfate therapy. Arch Intern Med 136:480–483

    CAS  PubMed  Google Scholar 

  • Navas D, Caillon J, Gras-Le Guen C, Jacqueline C, Kergueris MF, Bignon S, Potel G (2004) Comparison of in vivo intrinsic activity of cefepime and imipenem in a Pseudomonas aeruginosa rabbit endocarditis model: effect of combination with tobramycin simulating human serum pharmacokinetics. J Antimicrob Chemother 54:767–771

    CAS  PubMed  Google Scholar 

  • Nichols L, Maki DG (1985) The emergence of resistance to β-lactam antibiotics during treatment of Pseudomonas aeruginosa lower respiratory tract infections: is combination therapy the solution? Chemioterapia 4:102–109

    CAS  PubMed  Google Scholar 

  • Nicolau DP, Marangos MN, Nightingale CH, Patel KB, Cooper BW, Quintiliani R Jr, Courvalin P, Quintiliani R (1996) Efficacy of vancomycin and teicoplanin alone and in combination with streptomycin in experimental, low-level vancomycin-resistant, VanB-type Enterococcus faecalis endocarditis. Antimicrob Agents Chemother 40:55–60

    CAS  PubMed Central  PubMed  Google Scholar 

  • Olaison L, Schadewitz K (2002) Enterococcal endocarditis in Sweden, 1995–1999: can shorter therapy with aminoglycosides be used? Swedish Society of Infectious Diseases Quality Assurance Study Group for Endocarditis. Clin Infect Dis 34:159–166

    PubMed  Google Scholar 

  • Palmer SM, Rybak MJ (1996) Pharmacodynamics of once- or twice-daily levofloxacin versus vancomycin, with or without rifampin, against Staphylococcus aureus in an in vitro model with infected platelet-fibrin clots. Antimicrob Agents Chemother 40:701–705

    CAS  PubMed Central  PubMed  Google Scholar 

  • Pangon B, Joly V, Vallois JM, Abel L, Buré A, Brion N, Contrepois A, Carbon C (1987) Comparative efficacy of cefotiam, cefmenoxime, and ceftriaxone in experimental endocarditis and correlation with pharmacokinetics and in vitro efficacy. Antimicrob Agents Chemother 31:518–522

    CAS  PubMed Central  PubMed  Google Scholar 

  • Pankey GA, Ashcraft DS (2003) In vitro synergy of ciprofloxacin and gatifloxacin against ciprofloxacin-resistant Pseudomonas aeruginosa. Antimicrob Agents Chemother 49:2959–2964

    Google Scholar 

  • Paul M, Grozinsky S, Soares-Weiser K, Leibovici L (2009) Beta-lactam antibiotic monotherapy versus beta-lactam aminoglycoside antibiotic combination therapy for sepsis. Cochrane Database Syst Rev 1:CD003344

    Google Scholar 

  • Péchere JC, Marchou B, Michéa-Hamzehpour M, Auckenthaler R (1986) Emergence of resistance after therapy with antibiotics used alone or combined in a murine model. J Antimicrob Chemother 17(Suppl A):11–18

    PubMed  Google Scholar 

  • Pefanis A, Giamarellou H, Karayiannalkos P, Donta I (1993) Efficacy of ceftazidime and aztreonam alone and in combination with amikacin in experimental left-sided Pseudomonas aeruginosa endocarditis. Antimicrob Agents Chemother 37:308–313

    CAS  PubMed Central  PubMed  Google Scholar 

  • Pérez Salmerón J, Martínez García F, Roldán Conesa D, Lorente Salinas I, López Fornás F, Ruiz Gómez J, Gómez Gómez J, Segovia Hernández M, Valdés CM (2006) Comparative study of treatment with quinupristin-dalfopristin alone or in combination with gentamicin, teicoplanin, imipenem or levofloxacin in experimental endocarditis due to a multidrug-resistant Enterococcus faecium. Rev Esp Quimioter 19(3):258–266, Spanish

    PubMed  Google Scholar 

  • Peterson LR, Gerding DN, Moody JA, Fasching CE (1984) Comparison of azlocillin, ceftizoxime, cefoxitin and amikacin alone and in combination against Pseudomonas aeruginosa in a neutropenic-site rabbit model. Antimicrob Agents Chemother 25:545–552

    CAS  PubMed Central  PubMed  Google Scholar 

  • Placensia V, Borrell N, Maciá MD, Moya B, Pérez JL, Oliver A (2007) Influence of high mutation rates on the mechanisms and dynamics of in vitro and in vivo resistance development to single or combined antipseudomonal agents. Antimicrob Agents Chemother 51:2574–2581

    Google Scholar 

  • Potgieter E, Carmichael M, Koornhof HJ, Chalkley LJ (1992) In vitro antimicrobial susceptibility of viridans streptococci isolated from blood cultures. Eur J Clin Microbiol Infect Dis 11:543–546

    CAS  PubMed  Google Scholar 

  • Ribera E, Gómez-Jimenez J, Cortes E, del Valle O, Planes A, Gonzalez-Alujas T, Almirante B, Ocaña I, Pahissa A (1996) Effectiveness of cloxacillin with and without gentamicin in short-term therapy for right-sided Staphylococcus aureus endocarditis. A randomized, controlled trial. Ann Intern Med 125:969–974

    CAS  PubMed  Google Scholar 

  • Rice LB, Eliopoulos CT, Yao JD, Eliopoulos GM, Moellering RC Jr (1992) In vivo activity of the combination of daptomycin and fosfomycin compared with daptomycin alone against a strain of Enterococcus faecalis with high-level gentamicin resistance in the rat endocarditis model. Diagn Microbiol Infect Dis 15:173–176

    CAS  PubMed  Google Scholar 

  • Robaux MA, Dube L, Caillon J, Bignon D, Kergueris MF, Navas D, Le Conte P, Baron D, Potel G (2001) In vivo efficacy of continuous infusion versus intermittent dosing of ceftazidime alone or in combination with amikacin relative to human kinetic profiles in a Pseudomonas aeruginosa rabbit endocarditis model. J Antimicrob Chemother 14:517–622

    Google Scholar 

  • Robbins WC, Tompsett R (1951) Treatment of enterococcal endocarditis and bacteremia: results of combined therapy with penicillin and streptomycin. Am J Med 10:278–299

    CAS  PubMed  Google Scholar 

  • Rodríguez A, Vicente MV, Olay T (1987) Single- and combination-antibiotic therapy for experimental endocarditis caused by methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 31:1444–1445

    PubMed Central  PubMed  Google Scholar 

  • Rose WE, Leonard SN, Rybak MJ (2008) Evaluation of daptomycin pharmacodynamics and resistance at various dosage regimens against Staphylococcus aureus isolates with reduced susceptibilities to daptomycin in an in vitro pharmacodynamic model with simulated endocardial vegetations. Antimicrob Agents Chemother 52:3061–3067

    CAS  PubMed Central  PubMed  Google Scholar 

  • Rusnak MG, Drake TA, Hackbarth CJ, Sande MA (1984) Single versus combination antibiotic therapy for pneumonia due to Pseudomonas aeruginosa in neutropenic guinea pigs. J Infect Dis 149:980–985

    CAS  PubMed  Google Scholar 

  • Ryan RW, Kwasnik I, Tilton RC (1981) Methodological variation in antibiotic synergy tests against enterococci. J Clin Microbiol 13:73–75

    CAS  PubMed Central  PubMed  Google Scholar 

  • Safdar N, Handelsman J, Maki DG (2004) Does combination antimicrobial therapy reduce mortality in Gram-negative bacteraemia? A meta-analysis. Lancet Infect Dis 4:519–527

    PubMed  Google Scholar 

  • Sande MA, Courtney KB (1976) Nafcillin-gentamicin synergism in experimental staphylococcal endocarditis. J Lab Clin Med 88:118–124

    CAS  PubMed  Google Scholar 

  • Sande MA, Johnson ML (1975) Antimicrobial therapy of experimental endocarditis caused by Staphylococcus aureus. J Infect Dis 131:367–375

    CAS  PubMed  Google Scholar 

  • Schwank S, Blaser J (1996) Once-versus thrice-daily netilmicin combined with amoxicillin, penicillin, or vancomycin against Enterococcus faecalis in a pharmacodynamic in vitro model. Antimicrob Agents Chemother 40:2258–2261

    CAS  PubMed Central  PubMed  Google Scholar 

  • Selwyn S (1983) The history of antimicrobial agents. In: Clinical chemotherapy. Fundamentals, vol 1. Thieme-Stratton, New York

    Google Scholar 

  • Sexton DJ, Tenenbaum MJ, Wilson WR, Steckelberg JM, Tice AD, Gilbert D, Dismukes W, Drew RH, Durack DT (1998) Ceftriaxone once daily for four weeks compared with ceftriaxone plus gentamicin once daily for two weeks for treatment of endocarditis due to penicillin-susceptible streptococci. Endocarditis Treatment Consortium Group. Clin Infect Dis 27:1470–1474

    CAS  PubMed  Google Scholar 

  • Shanson DC, Tadayon M (1986) Activity of teicoplanin compared with vancomycin alone, and combined with gentamicin, against penicillin tolerant viridans streptococci and enterococci causing endocarditis. J Hosp Infect 7(Suppl A):65–72

    PubMed  Google Scholar 

  • Shanson DC, Tadayon M, Bakhtiar M (1986) Bactericidal activity of netilmicin compared with gentamicin and streptomycin, alone and in combination with penicillin, against penicillin tolerant viridans streptococci and enterococci. J Antimicrob Chemother 18:479–490

    CAS  PubMed  Google Scholar 

  • Siegman-Igra Y, Ravona R, Primerman H, Giladi M (1998) Pseudomonas aeruginosa bacteremia: an analysis of 123 episodes, with particular emphasis on the effect of antibiotic therapy. Int J Infect Dis 2:211–215

    CAS  PubMed  Google Scholar 

  • Standiford HD, de Maine JB, Kirby WMM (1970) Antibiotic synergism of enterococci. Arch Intern Med 126:255–259

    CAS  PubMed  Google Scholar 

  • Steed ME, Vidaillac C, Rybak MJ (2010) Novel daptomycin combinations against daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus in an in vitro model of simulated endocardial vegetations. Antimicrob Agents Chemother 54:5187–5192

    CAS  PubMed Central  PubMed  Google Scholar 

  • Stevens PJ, Hutchinson NA, Holliman RE (1992) High level gentamicin resistance in enterococcal and streptococcal isolates from blood culture. Med Lab Sci 49:16–19

    CAS  PubMed  Google Scholar 

  • Sun HY, Fujitani S, Quintiliani R, Yu VL (2011) Pneumonia due to P. aeruginosa: Part II: antimicrobial resistance, pharmacodynamic concepts, and antibiotic therapy. Chest 139:1172–1185

    PubMed  Google Scholar 

  • Tam VH, Schilling AN, Lewis RE, Melnick DA, Boucher AN (2004) Novel approach to characterization of combined pharmacodynamic effects of antimicrobial agents. Antimicrob Agents Chemother 48:4315–4321

    CAS  PubMed Central  PubMed  Google Scholar 

  • Tapper ML, Armstrong DA (1974) Bacteremia due to Pseudomonas aeruginosa complicated neoplastic disease: a progress report. J Infect Dis 130(Suppl):S14–S23

    PubMed  Google Scholar 

  • Thauvin C, Lecomte F, Le Boete I, Grise G, Lemeland JF (1989) Efficacy of ciprofloxacin alone and in combination with azlocillin in experimental endocarditis due to Pseudomonas aeruginosa. Infection 17:31–34

    CAS  PubMed  Google Scholar 

  • Torres C, Tenorio C, Lantero M, Gastañares MJ, Baquero F (1993 Nov) High-level penicillin resistance and penicillin-gentamicin synergy in Enterococcus faecium. Antimicrob Agents Chemother 37(11):2427–2431

    CAS  PubMed Central  PubMed  Google Scholar 

  • Tsaganos T, Skiadas I, Koutoukas P, Adamis T, Baxevanos N, Tzepi I, Pelekanou A, Giamarellos-Bourboulis EJ, Giamarellou H, Kanellakopoulou K (2008) Efficacy and pharmacodynamics of linezolid, alone and in combination with rifampicin, in an experimental model of methicillin-resistant Staphylococcus aureus endocarditis. J Antimicrob Chemother 62:381–383

    CAS  PubMed  Google Scholar 

  • Tsuji BT, Rybak MJ (2005) Short-course gentamicin in combination with daptomycin or vancomycin against Staphylococcus aureus in an in vitro pharmacodynamic model with simulated endocardial vegetations. Antimicrob Agents Chemother 49:2735–2745

    CAS  PubMed Central  PubMed  Google Scholar 

  • Tuazon CU, Gill V, Gill F (1986) Streptococcal endocarditis: single vs. combination antibiotic therapy and role of various species. Rev Infect Dis 8:54–60

    CAS  PubMed  Google Scholar 

  • Ulrich E, Trautmann M, Krause B, Bauernfeind A, Hahn H (1989) Comparative efficacy of ciprofloxacin, azlocillin, imipenem/cilastatin and tobramycin in a model of experimental septicemia due to Pseudomonas aeruginosa in neutropenic mice. Infection 5:311–315

    Google Scholar 

  • van Delden C (2007) Pseudomonas aeruginosa bloodstream infections: how should we treat them? Int J Antimicrob Agents 30S:S71–S75

    Google Scholar 

  • Varghese JM, Roberts JA, Lipman J (2011) Antimicrobial pharmacokinetic and pharmacodynamic issues in the critically ill with severe sepsis and septic shock. Crit Care Clin 27:19–34

    CAS  PubMed  Google Scholar 

  • Vazquez J, Perri MB, Thal LA, Donabedian SA, Zervos MJ (1993) Sparfloxacin and clinafloxacin alone or in combination with gentamicin for therapy of experimental ampicillin-resistant enterococcal endocarditis in rabbits. J Antimicrob Chemother 32:715–721

    CAS  PubMed  Google Scholar 

  • Vicente MV, Olay T, Rodríguez A (1981) Experimental endocarditis caused by Streptococcus sanguis: single and combined antibiotic therapy. Antimicrob Agents Chemother 20(1):10–14

    CAS  PubMed Central  PubMed  Google Scholar 

  • Vidal F, Mensa J, Almela M, Martínez JA, Marco F, Casals C, Gatell JM, Soriano E, Jimenez de Anta MT (1996) Epidemiology and outcome of Pseudomonas aeruginosa bacteraemia, with special emphasis on the influence of antibiotic treatment. Analysis of 189 episodes. Arch Intern Med 156:2121–2126

    CAS  PubMed  Google Scholar 

  • Vigliarolo L, Ramírez MS, Centrón D, Lopardo H (2007) Influence of penicillin minimum inhibitory concentration in the synergy between penicillin and gentamicin in viridans-group streptococci. Rev Argent Microbiol 39:107–112

    CAS  PubMed  Google Scholar 

  • Watanakunakorn C, Glotzbecker C (1979) Synergism with aminoglycosides of penicillin, ampicillin and vancomycin against non-enterococcal group-D streptococci and viridans streptococci. J Med Microbiol 10:133–138

    Google Scholar 

  • Yee Y, Farber B, Mates S (1986) Mechanism of penicillin-streptomycin synergy for clinical isolates of viridans streptococci. J Infect Dis 154:531–534

    CAS  PubMed  Google Scholar 

  • Yuan Z, Ledesma K, Singh R, Hou JG, Prince RA, Tam VH (2010) Quantitative assessment of combination antimicrobial therapy against multidrug-resistant bacteria in a murine pneumonia model. J Infect Dis 201:889–897

    CAS  PubMed  Google Scholar 

  • Zelenitsky SA, Karlowsky JA, Hoban DJ, Kabani A, Zhanel GG (1998) Once versus thrice daily tobramycin alone and in combination with cefazidime, ciprofloxacin and imipenem in an in vitro pharmacodynamic model. Chemotherapy 44:1–6

    CAS  PubMed  Google Scholar 

  • Zelenitsky SA, Iacovides H, Harding GK, Ariano RE (2004) Effect of antibiotic sequence on combination regimens against Pseudomonas aeruginosa in a multiple-dose, in vitro infection model. Diagn Microbiol Infect Dis 49:67–70

    CAS  PubMed  Google Scholar 

  • Zinner SH, Dudley M, Blaser J (1986) In vitro models for the study of combination antibiotic therapy in neutropenic patients. Am J Med 80(Suppl 6B):156–160

    CAS  PubMed  Google Scholar 

  • Zuravleff JJ, Chervenick P, Yu VL, Muder RR, Diven WF (1984) Addition of rifampin to ticarcillin-tobramycin combination for the treatment of Pseudomonas aeruginosa infections: assessment in a neutropenic mouse model. J Lab Clin Med 103:878–885

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, University of Adelaide and SA Pathology, Women’s and Children’s Hospital, 72 King William Road, North Adelaide, South Australia, 5006, Australia

    John Turnidge M.B., B.S., F.R.A.C.P., F.R.C.P.A., F.A.S.M.

  2. Department of Pediatrics, University of Adelaide and SA Pathology, Women’s and Children’s Hospital, 72 King William Road, North Adelaide, South Australia, 5006, Australia

    John Turnidge M.B., B.S., F.R.A.C.P., F.R.C.P.A., F.A.S.M.

  3. Department of Molecular and Biomedical Science, University of Adelaide and SA Pathology, Women’s and Children’s Hospital, 72 King William Road, North Adelaide, South Australia, 5006, Australia

    John Turnidge M.B., B.S., F.R.A.C.P., F.R.C.P.A., F.A.S.M.

Authors
  1. John Turnidge M.B., B.S., F.R.A.C.P., F.R.C.P.A., F.A.S.M.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to John Turnidge M.B., B.S., F.R.A.C.P., F.R.C.P.A., F.A.S.M. .

Editor information

Editors and Affiliations

  1. Division of Clinical Pharmacology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA

    Alexander A. Vinks

  2. Dept. Pharmaceutics, University of Florida, Gainesville College of Pharmacy, Gainesville, Florida, USA

    Hartmut Derendorf

  3. Dept. of Medical Microbiology, Radboudumc, Radboud University Nijmegen, Nijmegen, The Netherlands

    Johan W. Mouton

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this chapter

Cite this chapter

Turnidge, J. (2014). Drug–Drug Combinations. In: Vinks, A., Derendorf, H., Mouton, J. (eds) Fundamentals of Antimicrobial Pharmacokinetics and Pharmacodynamics. Springer, New York, NY. https://doi.org/10.1007/978-0-387-75613-4_8

Download citation

  • DOI: https://doi.org/10.1007/978-0-387-75613-4_8

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-75612-7

  • Online ISBN: 978-0-387-75613-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation